Painter, John A.
Wallender, Erika
Hill, Andrew N.
Hamel, Mary
Okine, Rafiq
Furrer, Eliane
Jalang’o, Rose
Keitany, Kibor K.
Kariuki, Simon
Nyang’au, Isabella
Seda, Brian
Samuels, Aaron M.
Westercamp, Nelli
Article History
Received: 8 February 2026
Accepted: 29 May 2026
First Online: 15 June 2026
Declarations
:
: Ethical clearance of MVIP evaluation was undertaken by the US Centers for Disease Control and Prevention Institutional Review Board, WHO Ethics Committee, Oxford Tropical Research Ethics Committee, Kenya Medical Research Institute Scientific and Ethics Review Unit, and Kenya Pharmacy and Poisons Board.
: Not applicable.
: The authors declare no competing interests.